The National Medicines Authority (Infarmed) ordered the immediate recall and suspension of batch 2MI24058A of the medication Meropenem Aurovitas 500mg. The measure was taken after the identification of non-conforming situations in the context of the manufacturing of the active substance of the medication. This decision aims to protect public health, ensuring that only medications that comply with all quality standards reach patients. Infarmed is the entity responsible for the regulation and supervision of medications in Portugal.

Business
Infarmed orders immediate recall and suspension of batch of Meropenem Aurovitas 500mg
SIC Notícias28 August 2026 at 16:50
Related articles



